Valuation check: PRTC's debt-to-equity ratio is 0.06, below the Finance sector average of 2.39.
Get informed when a big investor buys or sells
+ Follow0.06
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
PureTech Health Plc's debt-to-equity ratio stands at 0.06. That is below the Finance sector average of 2.39. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
PureTech Health Plc sits lower the Finance benchmark (2.39) with a debt-to-equity ratio of 0.06. That is roughly 97.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 0.06 is attractive depends on PureTech Health Plc's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how PureTech Health Plc's debt-to-equity ratio evolved across reporting periods, while the comparison chart places PRTC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Finance, debt-to-equity ratio is commonly used to spot outliers. PureTech Health Plc's reading of 0.06 (sector avg 2.39) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.